Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Ré, Ana Carolina S. | - |
Autor(es): dc.creator | Martins, Jayanaraian F. | - |
Autor(es): dc.creator | Cunha Filho, Marcílio Sérgio Soares da | - |
Autor(es): dc.creator | Gelfuso, Guilherme Martins | - |
Autor(es): dc.creator | Aires, Carolina P. | - |
Autor(es): dc.creator | Gratieri, Taís | - |
Data de aceite: dc.date.accessioned | 2021-10-14T17:28:13Z | - |
Data de disponibilização: dc.date.available | 2021-10-14T17:28:13Z | - |
Data de envio: dc.date.issued | 2021-05-20 | - |
Data de envio: dc.date.issued | 2021-05-20 | - |
Data de envio: dc.date.issued | 2021-01-18 | - |
Fonte completa do material: dc.identifier | https://repositorio.unb.br/handle/10482/40964 | - |
Fonte completa do material: dc.identifier | https://doi.org/10.1007/s13346-021-00901-0 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/608651 | - |
Descrição: dc.description | Candidiasis is a common opportunistic infection caused by fungi of the Candida genus that affects mainly mucocutaneous tissues (e.g., vaginal, oral, and mammary). This condition has been known for a long time; thus, innumerous topical and systemic treatments are already available on the market worldwide. Yet, recurrent superficial candidiasis (RSC) is an expected outcome, still lacking effective and convenient treatments. Although several individual conditions may contribute to disease recurrence, biofilms’ presence seems to be the main etiological factor contributing to antifungal resistance. More than proposing novel antifungal agents, current research seems to be focusing on improving the pharmaceutical technology aspects of formulations to address such a challenge. These include extending and improving intimate contact of drug delivery systems with the mucocutaneous tissues, increasing drug loading dose, and enhancing topical drug permeation. This review discusses the current understanding of the RSC and the use of pharmaceutical technology tools in obtaining better results. Even though several drawbacks of conventional formulations have been circumvented with the help of nano- or microencapsulation techniques and with the use of mucoadhesive formulation excipients, many challenges remain. In particular, the need to mask the unpalatable taste of formulations for the treatment of oral candidiasis, and the necessity of formulations with a “dryer” sensorial feeling and improved performances in providing higher bioavailability for the treatment of mammary and vaginal candidiasis. | - |
Publicador: dc.publisher | Springer Nature | - |
Relação: dc.relation | https://link.springer.com/article/10.1007%2Fs13346-021-00901-0 | - |
Direitos: dc.rights | Acesso Restrito | - |
Palavras-chave: dc.subject | Candidíase | - |
Palavras-chave: dc.subject | Reincidência | - |
Palavras-chave: dc.subject | Biofilme | - |
Palavras-chave: dc.subject | Tecnologia farmacêutica | - |
Título: dc.title | New perspectives on the topical management of recurrent candidiasis | - |
Aparece nas coleções: | Repositório Institucional – UNB |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: